This is an opportunity to buy a patented technology for the acceleration of clinical R&D.
Overview of the offer
A purchaser will acquire unique state-of-the-art stem cell Research and Development Lab Technologies. Generally, finding and pre-screening a candidate stem cell therapy requires 12-18 months. Such a prolonged period delays the development & launch of mass-market therapeutics and also precludes the combination of stem cell and genomic data for targeted/personalized medicine.
We offer you to buy a recently acquired EU patent for novel lab tech best suited for oncology, wound care, dental and hair loss. Technology for sale significantly reduces the amount of time needed to screen candidates for stem cell therapies from years to weeks, so can rapidly accelerate further development. The main result is provided is that candidate therapies are ready faster for further development and potential commercialization, enabling rapid time-to-market.
Reasons to buy the technology for acceleration of clinical R&D
- Accelerates drug discovery to lower costs and shorten time to market
- EU patent
- 3 published scientific articles in top journals by a famous scientist
- +41 scientific citations
Detailed information (the company, country, price, etc.) is available on request.
Check other offers for sale in the category “Health Care“.
